subsequent dose increases produce diminishing returns
GHK-Cu Doses for Benefits GHK-Cu doses vary depending on the method of administration (topical, oral, or injectable), and since it's not approved by the FDA for recovery enhancement, it doesn't have standardized dosages
2019;140(7):e294324
At this time, GPB is not Food and Drug Administration-approved nor guideline-recommended (AASLD 2014) for the treatment of HE, though it is mentioned as possible alternative therapy pending further study
But that year, the American Academy of Pediatrics (AAP) released guidelines stating that providers should offer medications to patients 12 and older with obesity, alongside lifestyle treatment
noted that although rare adverse events such as nausea, facial flushing, and redness at the injection site were noted, sermorelin appears to have a very favorable safety profile [5]